Development Level

Tbio 7 | 10,625
Tchem 1 | 1,890

Disease

ovarian cancer 8 | 8,484
Cancer 4 | 2,346
osteosarcoma 4 | 7,933
Multiple myeloma 3 | 1,327
Waldenstrons macroglobulinemia 3 | 765
astrocytoma 3 | 1,493
glioblastoma 3 | 5,572
lung cancer 3 | 4,466
pilocytic astrocytoma 3 | 3,086
Amyotrophic Lateral Sclerosis 2 | 431
Breast cancer 2 | 3,094
Cleidocranial dysplasia 2 | 10
Down syndrome 2 | 548
Hemangioma 2 | 35
Leukemia, Myelocytic, Acute 2 | 113
Rheumatoid Arthritis 2 | 1,160
acute myeloid leukemia 2 | 780
acute quadriplegic myopathy 2 | 1,157
chronic kidney disease 2 | 90
invasive ductal carcinoma 2 | 2,950
lung carcinoma 2 | 2,844
malignant mesothelioma 2 | 3,162
pediatric high grade glioma 2 | 2,712
psoriasis 2 | 6,685
subependymal giant cell astrocytoma 2 | 2,287
ulcerative colitis 2 | 2,087
Acute myelomonocytic leukemia 1 | 3
Alzheimer's disease 1 | 644
Bone Diseases, Developmental 1 | 25
COPD 1 | 113
Chronic Lymphocytic Leukemia 1 | 242
Cleft Palate, Isolated, And Mental Retardation 1 | 2
Cleft palate 1 | 125
Congenital Heart Defects 1 | 37
Esophageal cancer 1 | 21
Hematologic cancer 1 | 9
Hepatitis B 1 | 103
Heterotopic Ossification 1 | 2
Human immunodeficiency virus infectious disease 1 | 92
IGA Glomerulonephritis 1 | 454
Immune system cancer 1 | 38
Juvenile Myelomonocytic Leukemia 1 | 21
LEUKEMIA, ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO, 3 1 | 20
Malignant neoplasm of esophagus 1 | 18
Mammary Neoplasms 1 | 410
Muscle Weakness 1 | 92
Myeloid Leukemia, Chronic 1 | 22
Myofibrillar myopathy 1 1 | 5
Myofibrillar myopathy 3 1 | 4
Pick's disease 1 | 14
Platelet Disorder, Familial, with Associated Myeloid Malignancy 1 | 1
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 | 11
Precursor Cell Lymphoblastic Leukemia Lymphoma 1 | 42
Prostatic Neoplasms 1 | 471
Renal Cell Carcinoma 1 | 199
Squamous cell carcinoma of esophagus 1 | 82
Stevens-Johnson syndrome 1 | 78
Thrombocytopenia 1 | 105
Transient Myeloproliferative Disorder of Down Syndrome 1 | 2
active Crohn's disease 1 | 918
adrenocortical carcinoma 1 | 1,427
adult high grade glioma 1 | 2,148
astrocytic glioma 1 | 2,241
atypical teratoid / rhabdoid tumor 1 | 4,369
colon cancer 1 | 1,475
cutaneous lupus erythematosus 1 | 1,056
dermatomyositis 1 | 933
diabetes mellitus 1 | 1,663
ependymoma 1 | 2,514
fibroadenoma 1 | 557
gastric carcinoma 1 | 832
inflammatory breast cancer 1 | 404
intraductal papillary-mucinous adenoma (IPMA) 1 | 2,956
intraductal papillary-mucinous carcinoma (IPMC) 1 | 2,988
intraductal papillary-mucinous neoplasm (IPMN) 1 | 3,289
juvenile dermatomyositis 1 | 1,189
lung adenocarcinoma 1 | 2,713
medulloblastoma 1 | 1,524
medulloblastoma, large-cell 1 | 6,234
pancreatic cancer 1 | 2,300
pancreatic ductal adenocarcinoma liver metastasis 1 | 1,795
pituitary cancer 1 | 1,972
posterior fossa group A ependymoma 1 | 1,511
primary Sjogren syndrome 1 | 789
progressive supranuclear palsy 1 | 674
tuberculosis and treatment for 3 months 1 | 327
tuberculosis and treatment for 6 months 1 | 686

Tissue

Blood and immune system 8 | 17,995
Cardiovascular System 8 | 17,958
Digestive Tract 8 | 18,473
Endocrine System 8 | 18,512
Female tissues 8 | 18,647
Liver and Pancreas 8 | 18,136
Male tissues 8 | 17,969
Nervous System 8 | 18,561
Respiratory system 8 | 17,484
Skin and soft tissues 8 | 18,115
Urinary Tract 8 | 18,444

Target Family

Non-IDG 5 | 11,971
Transcription Factor 2 | 1,400
Enzyme 1 | 4,146

WikiPathways Pathway

Dual hijack model of Vif in HI... 8 | 8
Focal Adhesion-PI3K-Akt-mTOR-s... 303 | 303
GPCRs, Class A Rhodopsin-like 257 | 257
Circadian rythm related genes 200 | 200
Integrated Pancreatic Cancer P... 192 | 192
Focal Adhesion 190 | 190
Metapathway biotransformation 172 | 172
MAPK Signaling Pathway 167 | 167
Chemokine signaling pathway 164 | 164
EGF/EGFR Signaling Pathway 162 | 162
Insulin Signaling 160 | 160
Myometrial Relaxation and Cont... 157 | 157
Sudden Infant Death Syndrome (... 157 | 157
Allograft Rejection 156 | 156
Integrated Breast Cancer Pathw... 152 | 152
Calcium Regulation in the Card... 150 | 150
Regulation of Actin Cytoskelet... 149 | 149
Mesodermal Commitment Pathway 147 | 147
Brain-Derived Neurotrophic Fac... 144 | 144
NRF2 pathway 143 | 143
Endoderm Differentiation 141 | 141
Ectoderm Differentiation 138 | 138
Regulation of toll-like recept... 138 | 138
Angiopoietin Like Protein 8 Re... 132 | 132
TGF-beta Signaling Pathway 132 | 132
Adipogenesis 130 | 130
Proteasome Degradation 129 | 129
mRNA Processing 125 | 125
ESC Pluripotency Pathways 116 | 116
Spinal Cord Injury 116 | 116
DNA Damage Response (only ATM ... 112 | 112
Senescence and Autophagy in Ca... 106 | 106
Cell Cycle 104 | 104
Electron Transport Chain 103 | 103
Neural Crest Differentiation 101 | 101
Toll-like Receptor Signaling P... 101 | 101
Wnt Signaling Pathway and Plur... 101 | 101
Integrin-mediated Cell Adhesio... 100 | 100
B Cell Receptor Signaling Path... 97 | 97
Corticotropin-releasing hormon... 95 | 95
G Protein Signaling Pathways 94 | 94
Amino Acid metabolism 92 | 92
Apoptosis Modulation and Signa... 92 | 92
GPCRs, Other 92 | 92
TNF alpha Signaling Pathway 92 | 92
T-Cell antigen Receptor (TCR) ... 90 | 90
Androgen receptor signaling pa... 89 | 89
Cytoplasmic Ribosomal Proteins 89 | 89
Retinoblastoma (RB) in Cancer 87 | 87
Apoptosis 86 | 86
Selenium Micronutrient Network 85 | 85
Signaling Pathways in Glioblas... 83 | 83
MicroRNAs in cardiomyocyte hyp... 82 | 82
Alzheimers Disease 80 | 80
Notch Signaling Pathway 79 | 79
Leptin signaling pathway 76 | 76
Prolactin Signaling Pathway 76 | 76
Arrhythmogenic Right Ventricul... 74 | 74
Peptide GPCRs 74 | 74
miRNA Regulation of DNA Damage... 73 | 73
Primary Focal Segmental Glomer... 72 | 72
Type II interferon signaling (... 71 | 71
DNA Damage Response 69 | 69
G1 to S cell cycle control 69 | 69
Parkin-Ubiquitin Proteasomal S... 69 | 69
Sterol Regulatory Element-Bind... 69 | 69
AMP-activated Protein Kinase (... 68 | 68
Human Thyroid Stimulating Horm... 68 | 68
PPAR signaling pathway 67 | 67
Rac1/Pak1/p38/MMP-2 pathway 67 | 67
AGE/RAGE pathway 66 | 66
Association Between Physico-Ch... 66 | 66
Wnt Signaling Pathway 66 | 66
Folate Metabolism 65 | 65
Oncostatin M Signaling Pathway 65 | 65
Lung fibrosis 64 | 64
Pathways Affected in Adenoid C... 64 | 64
Endochondral Ossification 62 | 62
MECP2 and Associated Rett Synd... 62 | 62
Oxidation by Cytochrome P450 62 | 62
TYROBP Causal Network 61 | 61
Oxidative phosphorylation 60 | 60
T-Cell antigen Receptor (TCR) ... 60 | 60
Complement and Coagulation Cas... 59 | 59
Kit receptor signaling pathway 59 | 59
RIG-I-like Receptor Signaling 59 | 59
Preimplantation Embryo 58 | 58
IL-1 signaling pathway 55 | 55
RANKL/RANK (Receptor activator... 55 | 55
Copper homeostasis 54 | 54
ErbB Signaling Pathway 54 | 54
IL-4 Signaling Pathway 54 | 54
Interferon type I signaling pa... 54 | 54
Pathogenic Escherichia coli in... 54 | 54
TGF-beta Receptor Signaling 54 | 54
Apoptosis-related network due ... 53 | 53
Cardiac Hypertrophic Response 53 | 53
Cardiac Progenitor Differentia... 53 | 53
Synaptic Vesicle Pathway 51 | 51
Translation Factors 51 | 51
Wnt Signaling Pathway Netpath 51 | 51

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Cullin-5 CUL5 Tbio Non-IDG -1.93258 89.1 172
E3 ubiquitin-protein ligase RBX1 RBX1 Tbio Enzyme -1.88715 67.2 211
Polyubiquitin-B UBB Tbio Non-IDG 92.3 370
Core-binding factor subunit beta CBFB Tchem Transcription Factor -0.75660 5.68 264
DNA dC->dU-editing enzyme APOBEC-3G APOBEC3G Tbio Non-IDG -2.74317 642.2 396
Transcription elongation factor B polypeptide 1 ELOC Tbio Non-IDG -1.71575 47.2 133
Transcription elongation factor B polypeptide 2 ELOB Tbio Non-IDG -1.67281 36.7 229
Runt-related transcription factor 1 RUNX1 Tbio Transcription Factor -3.21648 1789.0 751